



Mitochondrial Impairment in Oligodendroglial Cells Induces Cytokine Expression and Signaling 1 
 2 
Miriam Scheld1, Athanassios Fragoulis2, Stella Nyamoya1,3, Adib Zendedel1, Bernd Denecke4, Barbara Krauspe5, 3 
Nico Teske3, Markus Kipp6, Cordian Beyer1, Tim Clarner1 4 
 5 
1Institute of Neuroanatomy, Faculty of Medicine, RWTH Aachen University, 52074 Aachen, Germany, 6 
mscheld@ukaachen.de 7 
2Department of Anatomy and Cell Biology, Faculty of Medicine,  8 
RWTH Aachen University, 52074 Aachen, Germany 9 
3Department of Anatomy II, Ludwig-Maximilians-University of Munich, 80336 Munich, Germany 10 
4IZKF Genomics Facility, Interdisciplinary Center for Clinical Research, RWTH Aachen University, 52074 11 
Aachen, Germany 12 
5Clinic for gynaecology and obstetrics, Faculty of Medicine, RWTH Aachen University, 52074 Aachen, 13 
Germany 14 
6Institute of Anatomy, University of Rostock, 18057 Rostock, Germany 15 
 16 
Abstract 17 
Widespread inflammatory lesions within the central nervous system grey and white matter are major 18 
hallmarks of multiple sclerosis. The development of full-blown demyelinating multiple sclerosis 19 
lesions might be preceded by preactive lesions which are characterized by focal microglia activation in 20 
close spatial relation to apoptotic oligodendrocytes. In this study, we investigated the expression of 21 
signaling molecules of oligodendrocytes that might be involved in initial microglia activation during 22 
preactive lesion formation. Sodium azide was used to trigger mitochondrial impairment and cellular 23 
stress in oligodendroglial cells in vitro. Among various chemokines and cytokines, IL6 was identified 24 
as a possible oligodendroglial cell-derived signaling molecule in response to cellular stress. Relevance 25 
of this finding for lesion development was further explored in the cuprizone model by applying short-26 
term cuprizone feeding (2 – 4 d) on male C57BL/6 mice and subsequent analysis of gene expression, 27 
in situ hybridization and histology. Additionally, we analyzed the possible signaling of stressed 28 
oligodendroglial cells in vitro as well as in the cuprizone mouse model. In vitro, conditioned medium 29 
of stressed oligodendroglial cells triggered the activation of microglia cells. In cuprizone-fed animals, 30 
IL6 expression in oligodendrocytes was found in close vicinity of activated microglia cells. Taken 31 
together, our data supports the view that stressed oligodendrocytes have the potential to activate 32 
microglia cells through a specific cocktail of chemokines and cytokines among IL6. IL6. Further studies 33 
will have to identify the temporal activation pattern of these signaling molecules, their cellular sources and 34 
impact on neuroinflammation. 35 
 36 
Introduction 37 
Stressed oligodendrocytes in close proximity to foamy macrophages and clustered microglia expressing HLA-38 




Groot, Bergers et al. 2001, Zeis, Probst et al. 2009). These preactive lesions are thought to precede the 40 
development of full-blown demyelinating MS lesions (De Groot, Bergers et al. 2001, Wuerfel, Bellmann-Strobl 41 
et al. 2004, van der Valk and Amor 2009). Therefore, it seems reasonable to assume that the initial microglia 42 
activation and clustering as observed in preactive lesions might be triggered by oligodendrocyte-derived 43 
signaling molecules. It has been shown that oligodendrocytes are able to secrete a variety of signaling molecules 44 
such as chemokines, cytokines and other regulatory proteins which are known to be involved in the regulation of 45 
immunological processes (Cannella and Raine 2004, Balabanov, Strand et al. 2007, Kummer, Broekhuizen et al. 46 
2007, Okamura, Lebkowski et al. 2007, Tzartos, Friese et al. 2008, Merabova, Kaminski et al. 2012, Ramesh, 47 
Benge et al. 2012, Moyon, Dubessy et al. 2015). For example, IFN-treated primary rat oligodendrocytes 48 
significantly induced the expression of the chemokines CXCL10, CCL2, CCL3, and CCL5 (Balabanov, Strand 49 
et al. 2007). Furthermore, the cytokines IL6 and IL8 and the chemokine CCL2 were significantly induced in the 50 
human oligodendrocyte cell line MO3.13 when confronted with Borrelia burgdorferi. Exposure to the same 51 
bacteria caused the induction of IL8 and CCL2 in a dose-dependent manner in primary human oligodendrocytes 52 
(Ramesh, Benge et al. 2012). 53 
So far, it is not completely understood which processes trigger oligodendrocyte stress and subsequent expression 54 
of signaling molecules. One factor leading to oligodendrocyte stress, impaired mitochondrial functions and 55 
increased levels of reactive oxygen species (Wang, Wu et al. 2013) might be the accumulation of mutations 56 
within the mitochondrial genome. It is known that the mtDNA is prone to mutations with a mutation rate that is 57 
about 10-fold higher than chromosomal DNA (Linnane, Marzuki et al. 1989). In comparison to other cell 58 
populations, oligodendrocytes have a reduced capacity to repair their mtDNA, possibly due to particularities in 59 
the expression of factors involved in DNA repairing mechanisms (Hollensworth, Shen et al. 2000). With respect 60 
to demyelination and oligodendrocyte pathology, both mutations in mitochondrial genes as well as oxidative 61 
stress play a role in lesion formation and disease progression in MS and MS-related animal models (Mahad, 62 
Lassmann et al. 2008, Mao and Reddy 2010, Su, Bourdette et al. 2013, Draheim, Liessem et al. 2016). 63 
As the sentinels and injury sensors of the central nervous system (CNS), microglia can be activated by many 64 
kinds of mechanical injury and pathological disturbances within the CNS (Perry, Andersson et al. 1993, 65 
Gehrmann, Matsumoto et al. 1995). In MS, the magnitude of myelin loss during demyelinating events positively 66 
correlates with the number of activated microglia cells (Clarner, Diederichs et al. 2012). Furthermore, 67 
microgliosis can be induced by leukocyte infiltration into the CNS (Scheld, Ruther et al. 2016, Ruther, Scheld et 68 
al. 2017). However, the listed factors are rather unlikely to contribute to the activation of microglia cells during 69 
the formation of preactive lesions, since the affected brain regions lack any signs of demyelination, leukocyte 70 
infiltration, astrogliosis or inciting agents such as viral or bacterial antigens (Gay, Drye et al. 1997, De Groot, 71 
Bergers et al. 2001, Barnett and Prineas 2004, Marik, Felts et al. 2007, van der Valk and Amor 2009). A growing 72 
body of evidence suggests that stressed oligodendrocytes might be active contributors to MS lesion formation by 73 
initiating microglia reactivity. Barnett and Prineas have reported areas with an extensive oligodendrocyte 74 
apoptosis and concomitant microgliosis in the absence of infiltrating immune cells in the normal appearing white 75 
matter of MS patients, thus indicating that oligodendrocyte loss precedes inflammatory demyelination (Barnett 76 
and Prineas 2004). 77 
In this study, we use the oligodendroglial cell line OLN93 to screen for oligodendrocyte-derived chemokines and 78 
cytokines that are potentially able to activate microglia cells. Subsequent culture experiments with the microglia 79 




cocktail of secreted proteins, which are responsible for microglia activation. Finally, IL6 expression was 81 
explored in the cuprizone model, which recapitulates distinct but important aspects of early MS lesion formation. 82 
 83 
Materials and methods 84 
Cell culture  85 
Cells of the oligodendroglial linage cell line OLN93 were received from Dr C. Richter-Landsberg (RRID: 86 
CVCL_5850; Oldenburg, Germany) and chosen as a model system because of strong similarities to primary 87 
oligodendrocytes regarding morphology and gene expression (Richter-Landsberg and Heinrich 1996). BV2 cell 88 
line was cultured according to Dr. E. Blasi (RRID: CVCL_0182; Modena, Italy) and chosen as a model system 89 
because of its suitability to study molecular mechanisms that control induction and expression of biological 90 
activities in microglia (Blasi, Barluzzi et al. 1990). Cell lines were not authenticated prior to experiments. None 91 
of the cell lines used in these experiments is listed as a commonly misidentified cell line by the International Cell 92 
Line Authentication Committee. OLN93 oligodendroglial cell line and BV2 microglial cell lines were 93 
maintained in Dulbecco’s Modified Eagle Medium supplemented with 5% (OLN93) and 10% (BV2) heat-94 
inactivated fetal bovine serum, penicillin G (10,000 units/mL), and streptomycin (10,000 µg/mL). For 95 
experiments, cells were seeded into 6-well dishes, 10 cm culture dishes or 75 cm2 flasks at densities of 3 x 105, 96 
5 x 106 and 2.3 x 106 cells per well, respectively. Before treatment, cells were cultivated for 24 h in starving 97 
medium (OLN93: SATO with 1% penicillin G/ streptomycin; BV2: DMEM supplemented with 0.5% fetal calf 98 
serum and 0.5% penicillin G/ streptomycin). Cells were cultivated in a humidified atmosphere of 5% CO2 at 99 
37 °C. 100 
 101 
Oligodendroglial cell conditioned medium (OCM) 102 
OLN93 cells were treated with 10 mM sodium azide (SA, Sigma Aldrich) or vehicle (UltraPure Distilled Water; 103 
Thermo Fisher Scientific) for 24 h. After washing twice with 1x phosphate buffered saline (PBS), cells were 104 
incubated with starving medium for a 24 h secretion period. The medium of each treatment group was pooled, 105 
centrifuged and filtered through a 20 µm cell strainer. BV2 microglia were incubated with OCM from SA treated 106 
cells (OCM-SA) for 6 h. Oligodendroglial starving medium and OCM from vehicle groups (OCM-vehicle) 107 
served as control. OCM was additionally used for ELISA analysis. See supplementary figure A for experimental 108 
overview. 109 
 110 
Cell Viability and metabolic activity assay  111 
To investigate the toxic effects of the applied SA concentrations, CytoTox 96® Non-Radioactive Cytotoxicity 112 
Assay and CellTiter-Blue® Cell Viability Assay (Promega G1780, G8081) were performed according to the 113 
manufacturer’s instructions. Brief, cells were seeded into an opaque-walled 96 tissue culture plate and treated 114 
with SA and vehicle for 24 h. Treatment of cells with a lysis solution served as a negative control as all cells are 115 
dead, medium without cells served as blank. Cells were incubated with CellTiter-Blue reagent until a change of 116 
color was observed, fluorescence was measured at 560/590 nm with the Tecan infinite M200 plate reader and 117 
processed with i-control 1.10 software. Medium of cells was incubated for 30 min with CytoTox96 reagent and 118 
the reaction was stopped with stop solution. Absorbance was measured at 490 nm with Tecan i-control software. 119 
Data are given in % of control fluorescence and absorbance values, respectively. No blinding was performed for 120 




Enzyme-linked immunosorbent assay 122 
IL6 ELISA was conducted using cell culture supernatants of vehicle and SA-treated OLN93 cells (OCM) 123 
according to the manufacturer’s protocol (Quantikine ELISA, R&D Systems). Color development of substrate 124 
solution (stabilized hydrogen peroxide and stabilized chromogen (tetramethylbenzidine)) was monitored with a 125 
Tecan infinite M200 plate reader at 450 nm with a wavelength correction at 540 nm and processed with i-control 126 
1.10 software. IL6 protein levels are displayed as absolute values in pg/ml. Experiments were performed with 127 
two biological and two technical replicates. 128 
 129 
Animals and cuprizone intoxication 130 
C57BL/6J male mice (19 ± 2 g) were obtained from Janvier and housed under standard laboratory conditions in 131 
the animal facility of the Uniklinik Aachen according to the Federation of European Laboratory Animal Science 132 
Association’s recommendations. Mice were maintained with food and water ad libitum in a 12 h light/dark cycle 133 
at controlled temperature and humidity (23 ± 2°C; 55% ± 10% humidity). Experimental procedures, i.e. 134 
cuprizone feeding, were approved by the Review Board for the Care of Animal Subjects of the district 135 
government (Nordrhein-Westfalen, Germany). At noon, mice received a diet containing 0.25 % cuprizone (bis-136 
cyclohexanone-oxaldihydrazone, Sigma Aldrich; choice of concentration via established protocols) for up to 2 d 137 
mixed into a ground standard rodent chow. The control group was fed with standard rodent chow. Animals were 138 
allocated to groups applying the following procedure: Animals were distributed across cages (three animals per 139 
cage; cage area 435 cm2) and each group consisted of mice with comparable weight. We used cards numbered 140 
from 1 to 2 for the respective experimental group (1 = control, 2 = 2 days cuprizone). The number on the card 141 
randomly assigned the cages to the respective group. Re-evaluation of cDNA samples of 1 – 4 d cuprizone-142 
treated mice were performed using previously published work from our research group (Krauspe, Dreher et al. 143 
2015). Size of groups for each experiment is given in the appropriate figure legends and an experimental 144 
overview is shown in supplementary figure B. 145 
 146 
Tissue preparation 147 
Mice were anaesthetized with ketamine/xylazine (100 mg/kg and 10 mg/kg; i.p. with 100 µl/10 g body weight) 148 
and transcardially perfused with either PBS or 3.7% formalin in PBS. Brains were removed to isolate RNA of 149 
the corpus callosum (CC) for gene expression analysis or whole brains were post-fixed in 3.7% formalin and 150 
subsequently embedded into paraffin for immunohistological analysis following established protocols (Clarner, 151 
Janssen et al. 2015). 152 
 153 
Immunohistological staining and fluorescence labeling 154 
For fluorescence and immunohistological analysis, 5 µm thick brain slides were cut with a microtome. Rabbit 155 
anti-IL6 (Abcam ab7737), mouse anti-OLIG2 (Millipore MABN50), donkey-anti-rabbit 488 and donkey-anti-156 
mouse 594 were used for fluorescence labeling (Life Technologies A21206, A21203). Signal specificity was 157 
validated by incubating slices with the respective secondary antibody without pre-incubation with the first 158 
antibody (see supplementary figure C). Furthermore, cross reactivity of secondary antibodies with each other or 159 
the false primary antibody was additionally excluded (data not shown). For chromogen double labeling, anti-160 
GFAP (Santa Cruz sc-6170), anti-IBA-1 (Millipore MABN92) and anti-APC (Millipore OP80) antibodies were 161 




ab6672) was visualized with an alkaline phosphatase (Zytomed Systems) and an AP Blue substrate that emits at 163 
680 nm (Vector Laboratories).  164 
 165 
In situ hybridization 166 
Commercial fluorescence in situ hybridization kits (QuantiGene View RNA in situ hybridization tissue assay; 167 
Affymetrix-Panomics) were used for double labeling of formalin-fixed, paraffin-embedded tissue, following the 168 
manufacturer’s recommendations. Protease digestion time was adjusted to 20 min. Probes directed against Olig2 169 
and Il6 were purchased from Affymetrix (Affymetrix-Panomics). Confocal images were captured using the 170 
LSM710 laser-scanning microscope station (Carl Zeiss). 171 
 172 
Chemokine and cytokine array 173 
RNA isolation was performed with RNeasy Micro Kit (Qiagen 74004). Cells were directly lysed with RLT 174 
buffer and homogenized with Precellys homogenizer. Further isolation procedures such as washing and DNA 175 
digestion was conducted in MinElute spin columns. RNA concentration was measured with NanoDrop 2000 176 
spectrometer. 500 ng RNA was reverse transcribed with RT2 First Strand Kit (Qiagen 330404). Genomic DNA 177 
was eliminated and RNA reverse transcribed according to the manufacturer’s instructions. Cytokine & 178 
Chemokine RT2 Profiler PCR Array (Qiagen PARN-150ZD) was performed with RT2 SYBR Green Mastermix 179 
and processed with Bio-Rad CFX connect cycler. PCR cycling program was composed of one 10 min 95°C hot 180 
start cycle and 40 cycles of 95°C 15 s and 60°C 1 min to perform fluorescence data collection. Results were 181 
analyzed using the Data analysis center from Qiagen (https://www.qiagen.com/de/shop/genes-and-182 
pathways/data-analysis-center-overview-page). -Actin, -2 microglobulin, hypoxanthine 183 
phosphoribosyltransferase 1, lactate dehydrogenase A and ribosomal protein large P1 served as reference genes. 184 
Furthermore, the array contained one genomic DNA control, three replicate reverse-transcription controls to test 185 
reverse-transcription efficiency and three replicate positive PCR controls to test PCR efficiency. Experiments 186 
were performed with one biological and one technical replicate. 187 
 188 
Gene expression analysis 189 
RNA for array validation and microglia gene expression analysis was isolated by using peqGold TriFast (Peqlab) 190 
and reverse-transcribed in a 20 µL reaction volume using a reverse-transcription kit (Thermo Fisher Scientific 191 
28025-021). cDNA levels were then analyzed by qPCR using SensiMix SYBR® & Fluorescein Kit (Bioline 192 
QT615-05) and Bio-Rad CFX connect cycler. The expression levels were calculated relative to the reference 193 
genes coding for glyceraldehyde 3-phosphate dehydrogenase or cyclophilin A using the Ct method. Primer 194 
sequences are given in table I. No blinding was performed for the evaluation of these data. Experiments were 195 
performed with at least 6 biological and 2 technical replicates if not stated otherwise. Furthermore, a gene array 196 
(Affymetrix) from the corpus callosum (CC) of control animals and animals that were fed cuprizone for 2 d, was 197 
re-evaluated with respect to those genes identified in the OLN93 gene expression study (Krauspe, Dreher et al. 198 




Table I. Forward and reverse primer sequences used for qPCR analysis. 200 
 201 
Statistical analysis 202 
Statistical analysis was performed using JMP10 and GraphPad Prism 5. Data are presented as arithmetic means 203 
± SEM. To test for equal variances, Bartlett test was performed. Data transformations via Boxcox for 204 
homoscedasticity are indicated if necessary. Shapiro-Wilk test was used to test for normal distribution. 205 
Parametric data were analyzed with one-way ANOVA followed by Tukey’s post hoc test for multiple 206 
comparisons or with Student’s t-test. Non-parametric data were analyzed with Kruskal-Wallis test followed by 207 
the Dunn’s multiple comparison or Mann-Whitney test. p < 0.05 was considered statistically significant. The 208 
following symbols were used to indicate the level of significance: *p < 0.05, **p < 0.005, ***p < 0.001; ns 209 




Sodium azide induces stress in oligodendroglial cells 214 
SA is a potent inhibitor of the mitochondrial respiratory chain and inhibits the mitochondrial complex IV which 215 
is responsible for the transfer of cytochrome c to an oxygen molecule (Bennett, Mlady et al. 1996, Teske, 216 
Liessem et al. 2018). To induce a breakdown of the mitochondrial inner transmembrane potential (i.e. sub-lethal 217 
mitochondrial stress reaction), the oligodendroglial cell line OLN93 was stimulated with 10 mM sodium azide 218 
(SA) for 24 h as previously described by Teske et al. (Teske, Liessem et al. 2018). Afterwards, cells were kept in 219 
culture for additional 24 h to produce OCM (oligodendroglial cell conditioned medium). To confirm that the 220 
used SA concentration was not inducing immediate cell death, lactate dehydrogenase (LDH) cytotoxicity assay 221 
and cell titer blue viability assay were performed after 24 h of SA-treatment. Results are shown in figure 1A. 222 
LDH levels in the cell culture supernatants were significantly increased after SA treatment compared to vehicle, 223 
indicating cell death; LDH levels of lysis control was significantly increased compared to both treatment groups 224 
Name Forward sequence 5’-3’ Reverse sequence 5’-3’ 
Arg1 mouse CTCCAAGCCAAAGTCCTTAGAG AGGAGCTGTCATTAGGGACATC 
Atf3 rat ACTGCGTTGTCCCACTCTGT TCATCTGAGAATGGCCGGGA 
Csf1 rat AGCAAGGAAGCGAACGAAC ATGTGGCTACAGTGCTCCGA 
Cyca rat GGCAAATGCTGGACCAAACAC TTAGAGTTGTCCACAGTCGGAGATG 
Ddit3 rat TGTTGAAGATGAGCGGGTGG GCTTTCAGGTGTGGTGGTGT 
Gapdh mouse TGTGTCCGTCGTGGATCTGA CCTGCTTCACCACCTTCTTGA 
Gdf15 rat TCAGCTGAGGTTCCTGCTGTTC GCTCGTCCGGGTTGAGTTG 
Il6 mouse GATACCACTCCCAACAGACCTG GGTACTCCAGAAGACCAGAGGA 
Il6 rat TCTCTCCGCAAGAGACTTCCA ATACTGGTCTGTTGTGGGTGG 
Lif rat TTTGCCGTCTGTGCAACAAG TGGACCACCGCACTAATGAC 
Nos2 mouse ACATCGACCCGTCCACAGTAT CAGAGGGGTAGGCTTGTCTC 




(left histogram in figure 1A). SA-induced LDH release was paralleled by a trend towards lower levels of 225 
metabolic activity in these cells (right histogram in figure 1A) however this difference was not statistically 226 
significant. Additionally, 10 mM SA-treated OLN93 cells did not show major morphological changes or loss of 227 
cell numbers at the microscopic level (figure 1B). Ddit3 and Atf3 are members of the integrated stress response 228 
which is closely connected to oxidative stress. Gene expression analysis of Ddit3 (Rutkowski, Arnold et al. 229 
2006, Puthalakath, O'Reilly et al. 2007) and Atf3 (Edagawa, Kawauchi et al. 2014) was measured after the 24 h 230 
secretion phase via qPCR to confirm endoplasmic reticulum stress in SA-treated cells on the transcriptional level 231 
(figure 1C). 232 
 233 
Stressed oligodendroglial cells secrete various cytokines and chemokines 234 
In a next step, we aimed to analyze the gene expression of secreted molecules that oligodendroglial cells produce 235 
upon SA-induced mitochondrial stress. To get a first hint about the possible identity of such signaling molecules, 236 
we performed PCR arrays that screened for mRNA expression levels of 84 cytokines and chemokines with one 237 
sample (n = 1). Out of the 84 investigated genes, 13 were induced by at least 2-fold when comparing the SA 238 
group with the vehicle group. Those 13 genes are displayed in figure 2A. IL6 and GDF15 were most robustly 239 
induced in stressed oligodendroglial cells compared to cells treated with vehicle. To confirm validity of the path 240 
finding gene array, we performed qPCR in independent samples from two additional experiments with each 241 
n = 6 for IL6, GDF15 and 3 randomly assigned genes (figure 2B). As indicated in figure 2B, IL6 gene 242 
expression and GDF15 gene expression were found to be induced > 12-fold in qPCR analysis in SA-treated 243 
OLN93 cells. Differences in between the gene expression measured in array analysis vs. qPCR are likely due to 244 
different evaluation strategies, i.e. different reference genes and subsequent software analysis and the measuring 245 
of only one sample in the PCR array. In comparison, genes for SPP1, LIF and CSF1 were induced 2.5- to 4-fold. 246 
In a next step, the relevance of the identified factors in vivo was investigated. Since short-term cuprizone 247 
intoxication mimics early lesion formation and induces stress in oligodendroglial cells, we re-evaluated gene 248 
array data from the CC of 2 d cuprizone-fed and control animals (Krauspe, Dreher et al. 2015). Results of this 249 
evaluation are shown in figure 2C. Out of the 13 investigated genes, 7 were significantly induced. Although 250 
GDF15 and CCL7 were highest induced in the tissue samples from cuprizone fed animals, oligodendroglial cells 251 
might be responsible - at least in part - for the increased IL6 expression in vivo. In a next step, we investigated 252 
whether oligodendroglial cells secrete IL6 on the protein level. Therefore, sandwich ELISA was performed using 253 
OCM from SA-treated and vehicle-treated oligodendroglial cells. Results are shown in figure 2E and 254 
demonstrate a 4-fold increase in IL6 levels upon SA-treatment. Our data show that stressed oligodendroglial 255 
cells express various signaling molecules that potentially activate microglia cells. To further investigate this 256 
hypothesis, the activation state of microglia cells was evaluated in OCM-stimulated BV2 microglia. 257 
Morphologically, no differences were found between cells growing in control medium (DMEM 0.5 %) and those 258 
cells grown in OCM-SA. Representative pictures after 6 hours incubation time are shown in figure 2D. 259 
Additionally performed arborization analysis and counting of bipolar cells did not reveal morphological changes 260 
in response to OCM-SA (supplementary figure E). 261 
Expression levels of typical pro- and anti-inflammatory microglia markers were measured by means of qPCR 6 h 262 
after beginning of treatment (see supplementary figure A for experimental overview). Results of these 263 
experiments are shown in figure 2F. Gene expression of the anti-inflammatory marker arginase 1 was induced 264 




vehicle-treated BV2 microglia. One factor that is known to be induced in microglia cells upon pro-inflammatory 266 
stimulation is NOS2 (Kempuraj, Thangavel et al. 2016). OCM-SA-treated BV2 microglia displayed an induced 267 
expression of NOS2 compared to control. Blocking of IL6 with anti-IL6 antibody only partly counteracted 268 
OCM-SA effects (figure 2G) and none of the used concentrations of IL6 protein (10, 30 and 50 ng/ml) was 269 
sufficient to show BV2 microglia responses with respect to the gene expression of both Nos2 and Arg1, 270 
indicating that other secreted molecules contribute to microglia activation in this scenario (supplementary figure 271 
F). 272 
 273 
Oligodendrocytes are a source of IL6 in vivo 274 
To investigate whether oligodendrocytes might be a relevant source of signaling molecules in vivo, we included 275 
short-term cuprizone-intoxicated mice (up to 4 d cuprizone) in the study. Since IL6 was highly induced in 276 
oligodendroglial cells in vitro, we focused on this molecule in this part of the study. Immunohistochemistry, 277 
qPCR and in situ hybridization were performed on brain slices of cuprizone-intoxicated animals. After 2 d of 278 
cuprizone intoxication, IBA-1 immunohistochemistry revealed that microglia display an activated cell 279 
morphology in the CC (i.e. less ramified, swollen somata) compared to control mice (figure 3A). Similar 280 
morphological changes as well as an increase in microglia cell numbers in early cuprizone-induced lesions have 281 
been published previously by our group after a 2 d exposure to cuprizone (Clarner, Janssen et al. 2015, Krauspe, 282 
Dreher et al. 2015). Re-evaluation via qPCR revealed that IL6 gene expression was increased about 5-fold in the 283 
CC after 2 d of cuprizone intoxication ((Krauspe, Dreher et al. 2015), figure 3B, n ≥ 3). This induction further 284 
increased up to 17-fold after 4 d of cuprizone intoxication. In situ hybridization showed an increase of IL6 285 
mRNA signals in the CC of cuprizone-intoxicated animals compared to controls (figure 3C, left panel). Double 286 
in situ hybridization (figure 3C, right panel) and validation by fluorescence double labeling of Olig2 and IL6 287 
proteins (figure 3D) as well as double chromogen labeling of APC and IL6 proteins (figure 3E) revealed 288 
oligodendroglial cells as one source of IL6 at this early time point (see supplementary figure B for experimental 289 
overview). Although APC as well labels astrocytes and neurons in the brain, the double-positive cell in figure 3E 290 
resembles morphologically strongly an oligodendrocyte. Three cuprizone-fed animals were investigated and 291 
IL6/Olig2 and APC positive cells were found in the CC in all three animals. Since confocal Z-stack analysis was 292 
necessary to undoubtedly identify double-positive cells, no quantification of the number of these cells could be 293 
performed. Note that oligodendrocytes are not the sole source of IL6 but also other glial cells such as astrocytes 294 
express IL6 after 2 days of cuprizone feeding (see supplementary figure D). Tezuka and colleagues also 295 
identified astrocytes as a source of IL6 in this model (Tezuka, Tamura et al. 2013). 296 
 297 
Discussion 298 
The contribution of stressed oligodendrocytes to the formation of inflammatory CNS lesions is only 299 
incompletely understood. Here, we induced oligodendrocyte stress by using the mitochondrial inhibitor SA in 300 
vitro and cuprizone intoxication in vivo. In vitro, this treatment caused a selective increase in the 301 
oligodendroglial expression of a variety of immune-modulatory factors such as IL6, GDF15 and a number of 302 
chemokines. The expression of IL6 in the in vivo situation was explored by qPCR analysis, ELISA, in situ 303 
hybridization and immunohistological staining of tissue from short-term cuprizone-intoxicated mice. 304 
Fluorescence double labeling and in situ hybridization of OLIG2 and IL6 identified oligodendrocytes as possible 305 




from SA-treated oligodendroglial cells might be relevant for the in vivo situation. It has to be mentioned at this 307 
point, that oligodendrocytes are not the sole source of these molecules in vivo. With respect to IL6, astrocytes 308 
and microglia have been shown to be additional sources in cuprizone intoxication. We would like to point out 309 
that due to the high number of possibly involved molecules and the highly complex interplay of different glia 310 
cells in the formation of early inflammatory lesions, knock-out mice deficient for single molecules would be of 311 
limited use to further investigate the role of oligodendrocytes in this scenario.  312 
Regarding the role of IL6 in CNS inflammation and regeneration in general it has been shown that on one hand, 313 
it is neuroprotective via accelerating nerve regeneration following trauma or spinal cord injury (Hirota, Kiyama 314 
et al. 1996, Yang, Wen et al. 2012) and protects mice from demyelination in the cuprizone model by inducing a 315 
specific activation state in microglia (Petkovic, Campbell et al. 2017). On the other hand, IL6 supports chronic 316 
inflammatory processes in disorders such as Alzheimer’s disease (Swardfager, Lanctot et al. 2010). In active 317 
demyelinating MS lesions, IL6 expression by astrocytes and macrophages is relevant for the preservation of 318 
oligodendrocytes (Schonrock, Gawlowski et al. 2000). IL6 signaling and mitochondrial functions are closely 319 
linked, since IL6 protects cells against a loss of mitochondrial complex IV after bacterial infection in mice 320 
(Maiti, Sharba et al. 2015). In the liver, IL6 is necessary for the repair of mitochondrial mutations caused by 321 
ethanol intoxication (Zhang, Tachibana et al. 2010). The physiological IL6 concentration in blood plasma 322 
samples from healthy humans is about 1 - 1.5 pg/ml whereas the concentration in inflammatory conditions is 323 
highly increased and might reach up to 1,000 pg/ml in sever inflammation (Damas, Ledoux et al. 1992, Seino, 324 
Ikeda et al. 1994, Ridker, Rifai et al. 2000). This is comparable to the concentrations we measured in the 325 
medium of stressed oligodendroglial cells (app. 800 pg/ml). Regarding the IL6 concentrations within the brain, 326 
both in healthy and inflamed tissue, only little is known. Therefore further studies will have to show the local 327 
IL6 concentrations and precise source within brain tissue in distinct pathologies. With respect to microglia cells, 328 
it has been shown that a concentration of 100 ng/ml does activate Nos2 mRNA expression in BV2 microglia 329 
(Matsumoto, Dohgu et al. 2018). Furthermore, IL6 (50 ng/ml) increases the mitochondrial Ca2+ levels in a 330 
STAT3-dependent manner in CD4+ T cells (Yang, Lirussi et al. 2015). By using Luciferin-expressing mice, we 331 
recently demonstrated that cuprizone intoxication causes an early induction of Nrf2-ARE signaling within the 332 
brain (Draheim, Liessem et al. 2016). Since Nrf2 has been shown to regulate IL6 expression (Wruck, Streetz et 333 
al. 2011), the increase in oxidative stress and subsequent Nrf2-activation might be a possible mechanism by 334 
which IL6 expression is initially triggered in oligodendrocytes in this model. Further studies including Nrf2-335 
deficient mice will have to show the link between oxidative stress and Nrf2 activity on one hand and the 336 
expression of IL6 in oligodendrocytes on the other hand. Given this data, we consider this early IL6 expression 337 
by oligodendrocytes during preactive lesion formation as a potential first “call for help” by metabolically 338 
dysfunctional or oxidatively challenged oligodendrocytes. 339 
Another member of the IL6 cytokine family that was induced upon SA-stimulation in this study is LIF, which 340 
similar to IL6 signals through the JAK/STAT pathway. It is required for the induction of inflammatory responses 341 
of microglia and astrocytes to brain damage (Holmberg and Patterson 2006). Furthermore, it has been shown that 342 
LIF plays a role in the initial infiltration of inflammatory cells into the CNS and in the neuronal response to brain 343 
injury (Sugiura, Lahav et al. 2000). Another highly induced molecule in our study was GDF15, also known as 344 
macrophage inhibitory cytokine-1. Bonaterra et al. showed that GDF15 is functionally linked to IL6 signaling 345 
since it regulates inflammatory IL6-dependent processes in vascular injury (Bonaterra, Zugel et al. 2012). A 346 




(Tsui, Chang et al. 2012). Despite these links to IL6 signaling, GDF15 plays a major role in regulating 348 
inflammatory pathways in injured tissues and is involved in pathological processes such as cancer, 349 
cardiovascular disorders, ischemia and atherosclerosis (Schlittenhardt, Schmiedt et al. 2005, Kempf, Eden et al. 350 
2006, Jiang, Wen et al. 2016). 351 
A number of chemokines were induced in SA-treated OLN93 cells that are known to be involved in microglia 352 
activation, including CXCL1 and CCL5 (Škuljec, Sun et al. 2011). The cytokine-like glycoprotein SPP1, also 353 
known as osteopontin, was induced about 4-fold in stressed oligodendroglial cells. Osteopontin has been 354 
implicated in the pathogenesis of several autoimmune diseases such as rheumatoid arthritis, autoimmune 355 
hepatitis and MS (Chabas, Baranzini et al. 2001, Yumoto, Ishijima et al. 2002, Mochida, Yoshimoto et al. 2004). 356 
Furthermore, osteopontin activity is found in MS lesions (Chen, Chen et al. 2009). It has been shown that the 357 
treatment of mixed cortical cultures with osteopontin leads to a stimulation of myelin basic protein expression 358 
and the formation of myelin sheaths indicating a putative role in remyelination and recovery (Selvaraju, 359 
Bernasconi et al. 2004). CSF1, a macrophage colony-stimulating factor was induced 2.5-fold in SA-stressed 360 
oligodendroglial cells and is involved in the proliferation, differentiation, and chemotactic activity of monocytes 361 
and macrophages. Interestingly, the survival of adult murine microglia cells seems to be fully dependent upon 362 
CSF1 receptor signaling, since all microglia cells can be eliminated from the CNS through CSF1R inhibitor 363 
administration (Elmore, Najafi et al. 2014). 364 
All of the above mentioned signaling molecules might account - either alone or in combination - for the effects, 365 
we observed in OCM-treated microglia cells. Our data indicate that not a sole oligodendroglial cell-derived 366 
molecule but rather a combination of different factors account for the activation of microglia cells. 367 
In summary, our data supports the view that stressed oligodendrocytes have the potential to activate microglia 368 
cells through a specific cocktail of chemokines and cytokines such as IL6. Further studies will have to identify 369 
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Figure 1 386 
(A) Shows the cytotoxicity (left) assay normalized to the lysis control and cell viability (right) assay normalized 387 
to the vehicle-treated cells of SA- and vehicle-treated OLN93 cells (eight culture wells, one experiment). (B) 388 
Microscopic pictures using the FLoidTM Cell Imaging station (Thermo Fisher Scientific) of vehicle and SA-389 
treated oligodendroglial cells did not reveal obvious signs of cell loss or death (20X magnification). (C) Gene 390 
expression analysis of Ddit3 and Atf3 (BoxCox-Y transformed) in vehicle- and SA-treated oligodendroglial cells 391 
indicating metabolic stress (at least six culture wells, five independent experiments). ns = not significant, 392 




Figure 2 394 
(A) Shows the fold difference of all chemokines and cytokines that were induced at least 2-fold in SA-treated 395 
OLN93 cells compared to control in the PCR array. (B) To validate the PCR array results, the gene expression 396 
was analyzed via qPCR on independent samples (at least six culture wells, two independent experiments). In (C) 397 
the re-evaluation of a gene array from the CC of 2d cuprizone-intoxicated mice is shown. Data are displayed as 398 
fold induction of control. Note that a selective induction of the identified factors in oligodendroglial cells might 399 
be obscured due to the fact that this array measured expression in the whole tissue and not exclusively in 400 
oligodendrocytes (three animals per group, one experiment, see Krauspe, Dreher et al. 2015). (D) Shows 401 
representative pictures after 6 hours incubation time of BV2 microglia cells with OCM-SA and DMEM 0.5 % 402 
(control). (E) IL6 protein levels increased up to 4-fold in stressed oligodendroglial cells versus unstressed 403 
oligodendroglial cells (BoxCox-Y transformed; six samples each group, two independent experiments). (F) 404 
Shows the gene expression results of pro- and anti-inflammatory markers arginase 1 (BoxCox-Y transformed) 405 
and Nos2 of OCM-stimulated microglia cells (at least five culture wells, four independent experiments). (G) 406 
Induction of Nos2 expression by OCM was partly (not significant) counteracted by anti-IL6 antibody in the 407 




Figure 3 409 
(A) IBA-1+ microglia cells display an activated morphology upon short-term cuprizone intoxication compared to 410 
control mice (scale bars 50 µm). (B) IL6 gene expression was increased in the CC after 2, 3, and 4 d of 411 
cuprizone intoxication compared to untreated animals (re-evaluation of cDNA of short-term cuprizone-fed mice; 412 
BoxCox-Y transformed). (C) At 2 d of 0.25% cuprizone intoxication, the signal for IL6 mRNA was increased 413 
compared to the control. In situ hybridization of OLIG2 and IL6 identified oligodendrocytes as source of IL6 414 
production after short-term cuprizone intoxication (scale bars for IL6 20 µm, for IL6/OLIG2 5 µm), which was 415 
further validated via fluorescence double labeling of OLIG2 and IL6 (scale bars for control 25 µm, for 2 d cup 416 
10 µm) (D) and double labeling of IL6 and APC (scale bars 10 µm) (E) (three animals per group, one experiment 417 








(A) Schematic illustration of the in vitro experimental setup for oligodendroglial cell stimulation and subsequent 420 
microglia stimulation with OCM. Oligodendroglial cells (OLN93) were stressed with 10 mM SA for 24 h, 421 
medium changed and incubated for 24 h with or without SA to produce OCM-vehicle and OCM-SA, 422 
respectively. OCM was then used to stimulate microglia cells for 6 h. (B) Time-line diagram of the 2 d cuprizone 423 
feeding in vivo experiments. (C) Signal specificity was validated by incubating slices with the respective 424 
secondary antibody without pre-incubation with the first antibody. Results for IL6 and OLIG2 negative controls 425 
are shown. Note that no signal was found within the examined tissue regions for any secondary antibody (scale 426 
bars 50 µm). Cross reactivity of secondary antibodies with each other or the false primary antibody was 427 
additionally excluded (data not shown). (D) Double labeling of IL6 with GFAP and IBA-1 (scale bars 10 µm) 428 
shows that also other glial cells than oligodendrocytes are possible sources of IL6 in 2 d cuprizone intoxication. 429 
No signal was found in the wildtype negative control (lower row) (scale bars 20 µm). (E) No morphological 430 
changes such as an increase in the number of bipolar cells or an increased arborization were found in OCM-SA-431 
stimulated compared to OCM-Veh-stimulated BV2 microglia cells. (F) Shows the gene expression results of 432 
arginase 1 and Nos2 (BoxCox-Y transformed) of IL6-stimulated microglia cells (four culture wells, one 433 
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